RhoA promotes osteoclastogenesis and regulates bone remodeling through mTOR-NFATc1 signaling.
- Published in:
- Molecular Medicine, 2023, v. 29, n. 1, p. 1, doi. 10.1186/s10020-023-00638-1
- By:
- Publication type:
- Article
Works about OSTEOCLASTOGENESIS
Results: 1176
1
2
Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL.
- Published in:
- Molecular Medicine, 2022, v. 28, n. 1, p. 1, doi. 10.1186/s10020-022-00568-4
- By:
- Publication type:
- Article
3
ATF1/miR-214-5p/ITGA7 axis promotes osteoclastogenesis to alter OVX-induced bone absorption.
- Published in:
- Molecular Medicine, 2022, v. 28, n. 1, p. 1, doi. 10.1186/s10020-022-00476-7
- By:
- Publication type:
- Article
4
Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis.
- Published in:
- Molecular Medicine, 2022, v. 28, n. 1, p. 1, doi. 10.1186/s10020-022-00449-w
- By:
- Publication type:
- Article
5
Administration of zoledronic acid alleviates osteoporosis in HIV patients by suppressing osteoclastogenesis via regulating RANKL expression.
- Published in:
- Molecular Medicine, 2021, v. 27, n. 1, p. 1, doi. 10.1186/s10020-021-00276-5
- By:
- Publication type:
- Article
6
Coenzyme Q10 inhibits RANKL‐induced osteoclastogenesis by regulation of mitochondrial apoptosis and oxidative stress in RAW264.7 cells.
- Published in:
- Journal of Biochemical & Molecular Toxicology, 2021, v. 35, n. 7, p. 1, doi. 10.1002/jbt.22778
- By:
- Publication type:
- Article
7
Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS).
- Published in:
- Clinical Rheumatology, 2018, v. 37, n. 11, p. 3057, doi. 10.1007/s10067-018-4322-9
- By:
- Publication type:
- Article
8
Osteoclastogenesis Requires Primary Cilia Disassembly and Can Be Inhibited by Promoting Primary Cilia Formation Pharmacologically.
- Published in:
- Cells Tissues Organs, 2024, v. 213, n. 3, p. 235, doi. 10.1159/000531098
- By:
- Publication type:
- Article
9
Mussel-inspired multifunctional surface through promoting osteogenesis and inhibiting osteoclastogenesis to facilitate bone regeneration.
- Published in:
- NPJ Regenerative Medicine, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41536-022-00224-9
- By:
- Publication type:
- Article
10
Detection of RANKL-producing cells and osteoclastic activation by the addition of exogenous RANKL in the regenerating scales of goldfish.
- Published in:
- Biological Sciences in Space, 2020, v. 34, p. 34, doi. 10.2187/bss.34.34
- By:
- Publication type:
- Article
11
Suppression of hematopoietic cell kinase ameliorates the bone destruction associated with inflammation.
- Published in:
- Modern Rheumatology, 2020, v. 30, n. 1, p. 85, doi. 10.1080/14397595.2018.1553266
- By:
- Publication type:
- Article
12
IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
- Published in:
- Modern Rheumatology, 2015, v. 25, n. 2, p. 270, doi. 10.3109/14397595.2014.950035
- By:
- Publication type:
- Article
13
Publisher Correction: Restrained Mitf-associated autophagy by Mulberroside A ameliorates osteoclastogenesis and counteracts OVX-Induced osteoporosis in mice.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
14
Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways.
- Published in:
- Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-01856-0
- By:
- Publication type:
- Article
15
Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways.
- Published in:
- Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-01856-0
- By:
- Publication type:
- Article
16
Restrained Mitf-associated autophagy by Mulberroside A ameliorates osteoclastogenesis and counteracts OVX-Induced osteoporosis in mice.
- Published in:
- Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-01847-1
- By:
- Publication type:
- Article
17
Comparison of the Effect of Oral Versus Intravenous Bisphosphonate Administration on Osteoclastogenesis in Advanced-Stage Medication-Related Osteonecrosis of the Jaw Patients.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 13, p. 2988, doi. 10.3390/jcm10132988
- By:
- Publication type:
- Article
18
Regulation of Th17 Cytokine-Induced Osteoclastogenesis via SKI306X in Rheumatoid Arthritis.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 1012, doi. 10.3390/jcm8071012
- By:
- Publication type:
- Article
19
Regulation of Th17 Cytokine-Induced Osteoclastogenesis via SKI306X in Rheumatoid Arthritis.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 7, p. 1012, doi. 10.3390/jcm8071012
- By:
- Publication type:
- Article
20
Inhibition of Osteoclastogenesis by Thioredoxin-Interacting Protein-Derived Peptide (TN13).
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 4, p. 431, doi. 10.3390/jcm8040431
- By:
- Publication type:
- Article
21
Novel Inhibitor of Keap1-Nrf2 Protein–Protein Interaction Attenuates Osteoclastogenesis In Vitro and Prevents OVX-Induced Bone Loss In Vivo.
- Published in:
- Antioxidants, 2024, v. 13, n. 7, p. 850, doi. 10.3390/antiox13070850
- By:
- Publication type:
- Article
22
Molecular Hydrogen Prevents Osteoclast Activation in a Glucocorticoid-Induced Osteoporosis Zebrafish Scale Model.
- Published in:
- Antioxidants, 2023, v. 12, n. 2, p. 345, doi. 10.3390/antiox12020345
- By:
- Publication type:
- Article
23
Astaxanthin Protects against Hyperglycemia-Induced Oxidative and Inflammatory Damage to Bone Marrow and to Bone Marrow-Retained Stem Cells and Restores Normal Hematopoiesis in Streptozotocin-Induced Diabetic Mice.
- Published in:
- Antioxidants, 2022, v. 11, n. 12, p. 2321, doi. 10.3390/antiox11122321
- By:
- Publication type:
- Article
24
FTY720 Attenuates LPS-Induced Inflammatory Bone Loss by Inhibiting Osteoclastogenesis via the NF-κB and HDAC4/ATF Pathways.
- Published in:
- Journal of Immunology Research, 2023, p. 1, doi. 10.1155/2023/8571649
- By:
- Publication type:
- Article
25
Unraveling the mechanisms behind joint damage: A subtype of myeloid monocyte mediates the transition from autoimmunity to joint destruction in rheumatoid arthritis.
- Published in:
- eLife, 2023, p. 1, doi. 10.7554/eLife.85553
- By:
- Publication type:
- Article
26
Osteogenesis and Osteoclastogenesis Regulation of the Midpalatal Area after Maxillary Suture Expansion Induced by Hyperbaric Oxygen Therapy (HBOT).
- Published in:
- Malaysian Journal of Medicine & Health Sciences, 2020, v. 16, n. Suppl4, p. 52
- By:
- Publication type:
- Article
27
The therapeutic effect of secretome from human umbilical cord-derived mesenchymal stem cells in age-related osteoporosis.
- Published in:
- Artificial Cells, Nanomedicine & Biotechnology, 2019, v. 47, n. 1, p. 1357, doi. 10.1080/21691401.2019.1596945
- By:
- Publication type:
- Article
28
Selenium donors inhibits osteoclastogenesis through inhibiting IL-6 and plays a pivotal role in bone metastasis from breast cancer.
- Published in:
- Toxicology Research, 2020, v. 9, n. 4, p. 544, doi. 10.1093/toxres/tfaa053
- By:
- Publication type:
- Article
29
Therapeutic potential of Triptolide in inhibiting breast cancer-induced bone destruction – PTHrP as a therapeutic target.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1512631
- By:
- Publication type:
- Article
30
Retraction: Corrigendum: A matrine derivative M54 suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by targeting ribosomal protein S5.
- Published in:
- 2025
- Publication type:
- Correction Notice
31
Retraction: A matrine derivative M54 suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by targeting ribosomal protein S5.
- Published in:
- 2025
- Publication type:
- Correction Notice
32
RETRACTED: A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2018.00022
- By:
- Publication type:
- Article
33
18β-Glycyrrhetinic Acid Inhibits Osteoclastogenesis <italic>In Vivo</italic> and <italic>In Vitro</italic> by Blocking RANKL-Mediated RANK–TRAF6 Interactions and NF-κB and MAPK Signaling Pathways.
- Published in:
- Frontiers in Pharmacology, 2018, p. N.PAG, doi. 10.3389/fphar.2018.00647
- By:
- Publication type:
- Article
34
A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5.
- Published in:
- Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.00022
- By:
- Publication type:
- Article
35
Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00693
- By:
- Publication type:
- Article
36
Nardosinone Suppresses RANKL-Induced Osteoclastogenesis and Attenuates Lipopolysaccharide-Induced Alveolar Bone Resorption.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00626
- By:
- Publication type:
- Article
37
Nucleotides modulate synoviocyte proliferation and osteoclast differentiation in macrophages with potential implications for rheumatoid arthritis.
- Published in:
- 3 Biotech, 2021, v. 11, n. 12, p. 1, doi. 10.1007/s13205-021-03052-8
- By:
- Publication type:
- Article
38
Majoon Chobchini attenuates arthritis disease severity and RANKL-mediated osteoclastogenesis in rheumatoid arthritis.
- Published in:
- 3 Biotech, 2021, v. 11, n. 10, p. 1, doi. 10.1007/s13205-021-02985-4
- By:
- Publication type:
- Article
39
Vitronectin regulates osteoclastogenesis and bone remodeling in a mouse model of osteoporosis.
- Published in:
- Anatomy & Cell Biology, 2024, v. 57, n. 2, p. 305, doi. 10.5115/acb.23.251
- By:
- Publication type:
- Article
40
Vibration accelerates orthodontic tooth movement by inducing osteoclastogenesis via transforming growth factor-β signalling in osteocytes.
- Published in:
- European Journal of Orthodontics, 2022, v. 44, n. 6, p. 698, doi. 10.1093/ejo/cjac036
- By:
- Publication type:
- Article
41
Investigation of optimal orthodontic force at the cellular level through three-dimensionally cultured periodontal ligament cells.
- Published in:
- European Journal of Orthodontics, 2016, v. 38, n. 4, p. 366, doi. 10.1093/ejo/cjv052
- By:
- Publication type:
- Article
42
The effect of different concentrations of topical ozone administration on bone formation in orthopedically expanded suture in rats.
- Published in:
- European Journal of Orthodontics, 2016, v. 38, n. 3, p. 281, doi. 10.1093/ejo/cjv045
- By:
- Publication type:
- Article
43
A RANKL-UCHL1-sCD13 negative feedback loop limits osteoclastogenesis in subchondral bone to prevent osteoarthritis progression.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-53119-2
- By:
- Publication type:
- Article
44
Long noncoding RNA Malat1 protects against osteoporosis and bone metastasis.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46602-3
- By:
- Publication type:
- Article
45
BHLHE40 promotes osteoclastogenesis and abnormal bone resorption via c-Fos/NFATc1.
- Published in:
- Cell & Bioscience, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13578-022-00813-7
- By:
- Publication type:
- Article
46
CCR5-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool.
- Published in:
- Cell & Bioscience, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13578-020-00410-6
- By:
- Publication type:
- Article
47
Low-dose IL-34 has no effect on osteoclastogenesis but promotes osteogenesis of hBMSCs partly via activation of the PI3K/AKT and ERK signaling pathways.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02263-3
- By:
- Publication type:
- Article
48
Low-dose IL-34 has no effect on osteoclastogenesis but promotes osteogenesis of hBMSCs partly via activation of the PI3K/AKT and ERK signaling pathways.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02263-3
- By:
- Publication type:
- Article
49
Morusin induces osteogenic differentiation of bone marrow mesenchymal stem cells by canonical Wnt/β-catenin pathway and prevents bone loss in an ovariectomized rat model.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02239-3
- By:
- Publication type:
- Article
50
Osteoclastic effects of mBMMSCs under compressive pressure during orthodontic tooth movement.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02220-0
- By:
- Publication type:
- Article